Despite the scarcity of treatments to halt or manage AD, FDA-approved AChE inhibitors, including rivastigmine, galantamine, and donepezil, along with memantine, an N-methyl-D-aspartate receptor antagonist, are used to alleviate the symptoms of the condition. The gene discussed is ACHE; the disease is Alzheimer disease.